Vnitr Lek 2020, 66(5):301-307 | DOI: 10.36290/vnl.2020.085

Vaccines recommended for diabetic patients

Petra Macounová, Rastislav Maďar
Ústav epidemiologie a ochrany veřejného zdraví, Lékařská fakulta, Ostravská univerzita

Diabetes mellitus is the name of a group of chronic diseases in which absolute or relative lack of insulin causes hyperglycemia. The hyperglycemic environment causes disorders of the cells of innate immunity, which leads to reduced function of the immune system, and therefore diabetics are more susceptible to infections. Due to immune dysfunction, infections are not only more common, but also more severe and with higher mortality than in people without diabetes. Nevertheless, in diabetics, an adequate immune response to the vaccine is maintained, so it is possible to use one of the most effective options for preventing infections, which is vaccination. When vaccinating diabetics, it is appropriate to prefer inactivated vaccines, the use of which is safe even in immunocompromised persons, of course, while respecting general contraindications. This article is focused on the five most common vaccine-preventable infections, including vaccines that are recommended for diabetics.

Keywords: diabetes mellitus, infection, immunization, prevention, vaccination, vaccination of diabetics.

Published: August 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Macounová P, Maďar R. Vaccines recommended for diabetic patients. Vnitr Lek. 2020;66(5):301-307. doi: 10.36290/vnl.2020.085.
Download citation

References

  1. Souček M, Svačina P. Vnitřní lékařství v kostce. 1. vydání. Praha: Grada Publishing, 2019. ISBN 978-80-271-2289-9.
  2. Škrha J. Diabetologie. 1. vyd. Praha: Galén, 2009. ISBN 978-80-7262-607-6.
  3. Pelikánová T, Bartoš V. Praktická diabetologie. 6. aktualizované a doplněné vydání. Praha: Maxdorf, 2018. Jessenius. ISBN 978-80-7345-559-0.
  4. Stručný přehled činnosti oboru diabetologie a endokrinologie za období 2007-2016. Ústav zdravotnických informací a statistiky ČR [online]. 2016 [cit. 2020-01-08]. Dostupné z: https://www.uzis.cz/publikace/zdravotnictvi-cr-strucny-prehled-cinnosti-oboru-diabetologie-endokrinologie-za-obdobi-2007
  5. Roglic G. Global report on diabetes. Geneva, Switzerland: World Health Organization, 2016. ISBN 9789241565257.
  6. Alves C, Casqueiro J, Casqueiro J. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian Journal of Endocrinology and Metabolism [online]. 2012, 16(7) [cit. 2020-01-10]. DOI: 10.4103/2230-8210.94253. ISSN 2230-8210. Dostupné z: http://www.ijem.in/text.asp?2012/16/7/27/94253 Go to original source... Go to PubMed...
  7. Geerlings S, Hoepelman A.Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunology & Medical Microbiology [online]. 1999; 26(3-4): 259-265 [cit. 2020-01-10]. DOI: 10.1111/j.1574-695X.1999.tb01397.x. ISSN 09288244. Dostupné z: https://academic.oup.com/femspd/article-lookup/doi/10.1111/j.1574-695X.1999.tb01397.x Go to original source... Go to PubMed...
  8. Maďar R, Benešová D, Brandejská D, et al. Vaccination of Patients with Diabetes Mellitus - a Retrospective Study. Central European Journal of Public Health [online]. 2011; 19(2): 98-101 [cit. 2020-05-14]. DOI: 10.21101/cejph.a3634. ISSN 12107778. Dostupné z: http://cejph.szu.cz/doi/10.21101/cejph.a3634.html Go to original source... Go to PubMed...
  9. Jeseňák M, Urbančíková I. Očkovanie v špeciálnych situáciách. 2., preprac. a rozšír. vyd. Praha: Mladá fronta, 2019. Aeskulap. ISBN 978-80-204-4324-3.
  10. Beran J. Diabetes mellitus a imunizace: Diabetes mellitus and immunization. Vnitřní lékařství. Praha: Česká lékařská společnost J. Ev. Purkyně, 2006; 52(5): 438-442. ISSN 0042-773X.
  11. Slíva J, Votava M. Farmakologie. 1. vyd. Praha: Triton, 2011. Lékařské repetitorium. ISBN isbn9788073875008.
  12. Farmakoterapeutické informace - Měsíčník pro lékaře a farmaceuty: Perorální antidiabetika v léčbě diabetes mellitus 2. typu. 2009, . ISSN 1211-0647. Dostupné z: http://www.sukl.cz/sukl/brezen-2009
  13. Šmahelová A. Perorální antidiabetika skupiny derivátů sulfonylurey [online]. Praha: Remedia, 2008, [cit. 2020-07-02]. ISSN 0862-8947. Dostupné z: http://www.remedia.cz/Clanky/Prehledy-nazory-diskuse/Peroralni-antidiabetika-skupiny-derivatu-sulfonylurey/6-F-zN.magarticle.aspx
  14. Suchopár J, Valentová Š. Compendium: Léčiva používaná v podmínkách ČR. 5. vyd. Panax Co, s.r.o., 2018. ISBN 978-80-902806-7-0.
  15. Kesavadev J, Misra A, Das AK, et al. Suggested use of vaccines in diabetes. Indian Journal of Endocrinology and Metabolism [online]. 2012; 16(6) [cit. 2020-05-14]. DOI: 10.4103/2230-8210.102982. ISSN 2230-8210. Dostupné z: http://www.ijem.in/text.asp?2012/16/6/886/102982 Go to original source... Go to PubMed...
  16. Dos Santos G, Tahrat H, Bekkat-Berkani R. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review. Human Vaccines & Immunotherapeutics [online]. 2018; 14(8): 1853-1866 [cit. 2020-05-14]. DOI: 10.1080/21645515.2018.1446719. ISSN 2164-5515. Dostupné z: https://www.tandfonline.com/doi/full/10.1080/21645515.2018.1446719 Go to original source... Go to PubMed...
  17. Rodriguez-Blanco T, Vila-Corcoles A, De Diego C, et al. Relationship between annual influenza vaccination and winter mortality in diabetic people over 65 years. Human Vaccines & Immunotherapeutics [online]. 2014; 8(3): 363-370 [cit. 2020-05-14]. DOI: 10.4161/hv.18548. ISSN 2164-5515. Dostupné z: http://www.tandfonline.com/doi/abs/10.4161/hv.18548 Go to original source... Go to PubMed...
  18. Kynčl J, Havlíčková M. Význam očkování proti chřipce a jeho optimální načasování. Státní zdravotní ústav [online]. [cit. 2020-01-15]. Dostupné z: http://www.szu.cz/tema/prevence/vyznam-ockovani-proti-chripce-a-jeho-optimalni-nacasovani
  19. Lelekis M, Stefani D. Prevention of Pneumococcal Disease in Patients with Chronic Cardiometabolic Diseases. International Journal of Caring Sciences [online]. 9(2), 1124-1128 [cit. 2020-01-20]. Dostupné z: https://www.semanticscholar.org/paper/Prevention-of-Pneumococcal-Disease-in-Patients-with-Lelekis-Stefani/578ff7d91fd2633e949fa76c45b816ad690c86f1
  20. Jackson L, Gurtman A, Van Cleeff M, et al. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine [online]. 2013; 31(35), 3594-3602 [cit. 2020-05-14]. DOI: 10.1016/j.vaccine.2013.04.084. ISSN 0264410X. Dostupné z: https://linkinghub.elsevier.com/retrieve/pii/S0264410X13005860 Go to original source... Go to PubMed...
  21. PREVENAR 13: Souhrn údajů o přípravku. Státní ústav pro kontrolu léčiv [online]. [cit. 2020-05-19]. Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0194312&tab=texts
  22. PNEUMOVAX 23: Souhrn údajů o přípravku. Státní ústav pro kontrolu léčiv [online]. [cit. 2020-05-19]. Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0236387&tab=texts
  23. Sawier M, Hoerger T, Murphy T, et al. Use of hepatitis B vaccination for adults with diabetes mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Recommendations of the Advisory Committee on Immunization Practices (ACIP). JAMA The Journal of the American Medical Association. 2012; 307: 659-662.
  24. Zhang X, Zhu X, Ji Y, et al. Increased risk of hepatitis B virus infection amongst individuals with diabetes mellitus. Bioscience Reports [online]. 2019; 39(3) [cit. 2020-05-15]. DOI: 10.1042/BSR20181715. ISSN 0144-8463. Dostupné z: https://portlandpress.com/bioscirep/article/doi/10.1042/BSR20181715/111013/Increased-risk-of-hepatitis-B-virus-infection Go to original source... Go to PubMed...
  25. Schillie S, Spradling P, Murphy T. Immune Response of Hepatitis B Vaccine Among Persons With Diabetes: A systematic review of the literature. Diabetes Care [online]. 2012; 35(12): 2690-2697 [cit. 2020-05-15]. DOI: 10.2337/dc12-0312. ISSN 0149-5992. Dostupné z: http://care.diabetesjournals.org/cgi/doi/10.2337/dc12-0312 Go to original source... Go to PubMed...
  26. Macounová P. Virové hepatitidy v Pardubickém kraji. Ostrava, 2019.. Diplomová práce. Ostravská univerzita, Lékařská fakulta. Vedoucí práce RNDr. Aleš Hozák.
  27. Papagianni M, Metallidis S, Tziomalos K. Herpes Zoster and Diabetes Mellitus: A Review. Diabetes Therapy [online]. 2018; 9(2): 545-550 [cit. 2020-05-19]. DOI: 10.1007/s13300-018-0394-4. ISSN 1869-6953. Dostupné z: http://link.springer.com/10.1007/s13300-018-0394-4 Go to original source... Go to PubMed...
  28. Muñoz-Quiles C, López-Lacrot M, Ampudia-Blasco F, et al. Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014. Human Vaccines & Immunotherapeutics [online]. 2017; 13(11): 2606-2611 [cit. 2020-05-19]. DOI: 10.1080/21645515.2017.1368600. ISSN 2164-5515. Dostupné z: https://www.tandfonline.com/doi/full/10.1080/21645515.2017.1368600 Go to original source... Go to PubMed...
  29. Suaya J, Chen S-Y, Qian LI, et al. Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States. Open Forum Infectious Diseases. 2014, 1(2). DOI: 10.1093/ofid/ofu049. ISSN 2328-8957. Dostupné z: https://doi.org/10.1093/ofid/ofu049 Go to original source... Go to PubMed...
  30. SHINGRIX: Souhrn údajů o přípravku. Státní ústav pro kontrolu léčiv [online]. [cit. 2020-05-20]. Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0222844&tab=texts
  31. VARILRIX: Souhrn údajů o přípravku. Státní ústav pro kontrolu léčiv [online]. [cit. 2020-06-30]. Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0010277&tab=texts
  32. Kiliç, D. Seroprevalence of tetanus immunity among noninsulin-dependent diabetes mellitus patients. Journal of Diabetes and its Complications [online]. 2003; 17(5): 258-263 [cit. 2020-05-20]. DOI: 10.1016/S1056-8727(02)00255-6. ISSN 10568727. Dostupné z: https://linkinghub.elsevier.com/retrieve/pii/S1056872702002556 Go to original source... Go to PubMed...
  33. Soulsby H, Russell-Jones D. Does diabetes put you at risk of tetanus?. Practical Diabetes International [online]. 2010; 27(9): 381-382 [cit. 2020-05-20]. DOI: 10.1002/pdi.1530. ISSN 13578170. Dostupné z: http://doi.wiley.com/10.1002/pdi.1530 Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.